Huang; Ru Chih C.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Huang; Ru Chih C..The latest application filed is for "in vivo amelioration of endogenous anti-tumor autoantibodies targeting surface tumor antigens via low-dose p4n".

Company Profile

2.23.20

Huang; Ru Chih C. - Baltimore MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
In Vivo Amelioration Of Endogenous Anti-tumor Autoantibodies Targeting Surface Tumor Antigens Via Low-dose P4n App 20190381026 - Huang; Ru Chih C. ; et al.	2019-12-19
In Vivo Amelioration Of Endogenous Anti-tumor Autoantibodies Targeting Surface Tumor Antigens Via Low-dose P4n App 20190111040 - Huang; Ru Chih C. ; et al.	2019-04-18
Suppression of cancer growth and metastasis using nordihydroguaiaretic acid derivatives with metabolic modulators Grant RE46,907 - Huang , et al. June 26, 2	2018-06-26
Bacterial expression plasmid Grant 9,284,565 - Huang , et al. March 15, 2	2016-03-15
Synergistic antiviral compositions comprising a viral attachment inhibitor, an integration inhibitor, and a proviral transcription inhibitor, and their use Grant 9,259,433 - Huang , et al. February 16, 2	2016-02-16
Synergistic Antiviral Compositions Comprising A Viral Attachment Inhibitor, An Integration Inhibitor, And A Proviral Transcription Inhibitor, And Their Use App 20150238511 - Huang; Ru Chih C. ; et al.	2015-08-27
Suppression of cancer growth and metastasis using nordihydroguaiaretic acid derivatives with 7-hydroxystaurosporine Grant 9,101,567 - Huang , et al. August 11, 2	2015-08-11
Conjugates of nitroimidazoles and their use as chemotherapeutic agents Grant 9,084,779 - Huang , et al. July 21, 2	2015-07-21
Synergistic antiviral compositions comprising a viral attachment inhibitor, integration inhibitor, and proviral transcription inhibitor Grant 9,005,889 - Huang , et al. April 14, 2	2015-04-14
Conjugates Of Nitroimidazoles And Their Use As Chemotherapeutic Agents App 20140186266 - Huang; Ru Chih C. ; et al.	2014-07-03
Novel Bacterial Expression Plasmid App 20140065699 - Huang; Ru Chih C. ; et al.	2014-03-06
Methods and compositions for treatment of intraepithelial neoplasia Grant 8,440,648 - Frazer , et al. May 14, 2	2013-05-14
Heterocyclic and carbonate derivatives of NDGA and their use as new anti-HIV and anti-cancer agents Grant 8,420,692 - Huang , et al. April 16, 2	2013-04-16
Suppression Of Cancer Growth And Metastasis Using Nordihydroguaiaretic Acid Derivatives With 7-hydroxystaurosporine App 20130053335 - Huang; Ru Chih C. ; et al.	2013-02-28
Method for treatment of tumors using nordihydroguaiaretic acid derivatives Grant 8,318,815 - Huang , et al. November 27, 2	2012-11-27
Methods and Compositions for Delivery of Catecholic Butanes for Treatment of Tumors App 20110135711 - Huang; Ru Chih C. ; et al.	2011-06-09
Combinational Paradigm Combating Hiv, Hiv/hsv, Or Hiv/hpv Infections In Humans Using Small Molecular Weight Compounds From Plants App 20100173861 - Huang; Ru Chih C. ; et al.	2010-07-08
Heterocyclic and carbonate derivatives of NDGA and their use as new anti-HIV and anti-cancer agents Grant 7,741,357 - Huang , et al. June 22, 2	2010-06-22
Methods for delivery of catecholic butanes for treatment of tumors Grant 7,728,036 - Huang , et al. June 1, 2	2010-06-01
Method for the suppression of viral growth Grant RE40,246 - Huang , et al. April 15, 2	2008-04-15
Methods and Compositions for Treatment of Intraepithelial Neoplasia App 20080004346 - Frazer; Neil ; et al.	2008-01-03
Antiviral compositions and methods of use Grant 7,071,227 - Huang , et al. July 4, 2	2006-07-04
Methods and compositions for delivery of catecholic butanes for treatment of tumors App 20060141025 - Huang; Ru Chih C. ; et al.	2006-06-29
Methods and compositions for delivery of catecholic butanes for treatment of obesity App 20060141047 - Heller; Jonathan ; et al.	2006-06-29
Nordihydroguaiartic derivatives for use in treatment of tumors App 20050267208 - Huang, Ru Chih C. ; et al.	2005-12-01
Nordihydroguaiartic derivatives for use in treatment of tumors Grant 6,958,411 - Huang , et al. October 25, 2	2005-10-25
Method for regulation of gene expression in eukaryotic cells using nordihydroguaiaretic acid derivatives Grant 6,777,444 - Huang , et al. August 17, 2	2004-08-17
Method for treatment of tumors using nordihydroguaiaretic acid derivatives App 20040127562 - Huang, Ru Chih C. ; et al.	2004-07-01
Method for treatment of tumors using nordihydroguaiaretic acid derivatives App 20030171416 - Huang, Ru Chih C. ; et al.	2003-09-11
Method for treatment of tumors using nordihydroguaiaretic acid derivatives Grant 6,608,108 - Huang , et al. August 19, 2	2003-08-19
Nordihydroguaiartic derivatives for use in treatment of tumors App 20030065016 - Huang, Ru Chih C. ; et al.	2003-04-03
Antiviral compositions and methods of use App 20020151584 - Huang, Ru Chih C. ; et al.	2002-10-17
Method for treatment of tumors using nordihydroguaiaretic acid derivatives App 20020065310 - Huang, Ru Chih C. ; et al.	2002-05-30
Method for the suppression of viral growth Grant 6,291,524 - Huang , et al. September 18, 2	2001-09-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.